'First of its kind' drug that delays type 1 diabetes by up to three years is approved by the NHS

Daily Mail Daily Mail

The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.

Read full article at Daily Mail →